APA (7th ed.) Citation

Bachelez, H., Griffiths, C. E. M., Papp, K. A., Hall, S., Merola, J. F., Feldman, S. R., . . . Young, P. (2024). Tofacitinib efficacy, patient‐reported outcomes and safety in patients with psoriasis and a medical history of psoriatic arthritis: Pooled analysis of two Phase III studies. Journal of the European Academy of Dermatology & Venereology, 38(7), e557. https://doi.org/10.1111/jdv.19701

Chicago Style (17th ed.) Citation

Bachelez, H., et al. "Tofacitinib Efficacy, Patient‐reported Outcomes and Safety in Patients with Psoriasis and a Medical History of Psoriatic Arthritis: Pooled Analysis of Two Phase III Studies." Journal of the European Academy of Dermatology & Venereology 38, no. 7 (2024): e557. https://doi.org/10.1111/jdv.19701.

MLA (9th ed.) Citation

Bachelez, H., et al. "Tofacitinib Efficacy, Patient‐reported Outcomes and Safety in Patients with Psoriasis and a Medical History of Psoriatic Arthritis: Pooled Analysis of Two Phase III Studies." Journal of the European Academy of Dermatology & Venereology, vol. 38, no. 7, 2024, p. e557, https://doi.org/10.1111/jdv.19701.